How To Build Relationships And Enhance Happiness: 4 Insights From Neuroscience – Forbes

More From ForbesCharting A Policy On Covid-19 Vaccinations: What Employers Need To Know","scope":{"topStory":{"title":"Charting A Policy On Covid-19 Vaccinations: What Employers Need To Know","uri":"https://www.forbes.com/sites/meghanbiro/2021/04/10/charting-a-policy-on-covid-19-vaccinations-what-employers-need-to-know/","date":{"monthDayYear":"Apr 10, 2021","hourMinute":"03:35","amPm":"pm","isEDT":true},"index":1}},"id":"c9oiq6dk3kio0"},{"textContent":"

Apr 10, 2021,03:06pm EDT

Apr 10, 2021,10:00am EDT

Apr 10, 2021,08:56am EDT

Apr 10, 2021,07:04am EDT

Apr 9, 2021,02:55pm EDT

Apr 9, 2021,10:55am EDT

Apr 9, 2021,09:11am EDT

Read this article:
How To Build Relationships And Enhance Happiness: 4 Insights From Neuroscience - Forbes

Neuroscience research finds distinct advertising differences across audio, radio and podcasting – CMO

Radio, podcasting and music streaming are distinctively processed by consumers, leading to differences in their strengths and effectiveness as advertising channels, a new neuro research study claims.

The fresh research, which has been conducted by neuroscience specialist, Dr Shannon Bosshard, in partnership with Australian Radio Networks Neuro Lab, sought to understand how consumers brains respond different to distinct audio formats, and the impact advertising has in each of them. To do this, it analysed more than 40,000 datapoints every second across the different audio formats and mapped brain activity of people engaging with both audio content and advertising.

According to the Sound you can see research, radio showed the strongest ability to engage listeners and for extended periods of time, racking up 60 per cent more neural engagement than other audio formats. Podcasts, meanwhile, were found to provide an environment that lends itself to higher levels of memory encoding, while music streaming options showed the strongest impact in promoting positive attitudes towards brands.

In describing the research, Dr Bosshard said radio, podcasting and music streaming are fundamentally different, thereby offering advertisers with unique opportunities to promote brands. For example, the findings highlighted a variance of up to 170 per cent in terms of attitudes around advertising when content and advertising dont match in these different audio channels.

ARN positioned the research work as the first go-to-market piece of research in this space measuring attention, engagement, attitude and memory and part of an ongoing initiative to better understand audios distinct role and impact for brands.

Up until now, no commercial or academic entity has assessed the differences in these three audio products, Dr Bosshard commented. This is the first time that anyone has demonstrated, from the perspective of the brain, that radio, podcasting and music streaming are processed differently and should be treated differently, in the same manner that audio and audio-visual mediums have been.

ARN director of research and insights, Justin Stone, said initial responses from agencies to the research has been enthusiastic. The use of neuroscience to complement traditional marketing techniques will produce a much more comprehensive view of how our listeners interact with audio formats, he said.

ARN said its Neuro Lab is now working with clients on how to evaluate and optimise impact across the three areas of focus. The lab was first established late in 2020 as an in-house media research initiative to support ARNs portfolio of products, including radio stations such as KIIS, the Pure Gold network and 96FM as well as the iHeartRadio music streaming and podcast network.

The findings come just weeks after the Interactive Advertising Bureau (IAB)of Australia published its latest Advertising Audio State of the Nation Report Wave 5, which showed podcasting and streaming digital audio advertising increased in 2020. The report found 69 per cent of media agencies now reporting streaming digital audio advertising as a significant or regular part of their activity and 36 per cent report podcast advertising as a significant or regular part of their activity.

Dont miss out on the wealth of insight and content provided by CMO A/NZ and sign up to our weekly CMO Digest newsletters and information services here.

You can also follow CMO on Twitter:@CMOAustralia, take part in the CMO conversation on LinkedIn:CMO ANZ,follow our regular updatesvia CMO Australia's Linkedin company page.

Follow this link:
Neuroscience research finds distinct advertising differences across audio, radio and podcasting - CMO

ANU plans to end neuroscience research – The Science Show – ABC News

The restructure of the College of Health and Medicine would see the end of neuroscience research at the Eccles Institute for Neuroscience at the Australian National University. 23 staff will lose their jobs on top of the 30 jobs lost in 2020. Sir John Eccles, after whom the Institute was named made pioneering discoveries on how nerves work. He was awarded the Nobel Prize, the first awarded to any researcher at ANU. John Eccles also helped set up the first undergraduate honours course at the university. David Mark and Jonathan Webb respond to the announcement.

ANU plans to end neuroscience research as it struggles to save $103 million annually - ABC News

A portrait of Sir John Eccles - Australian Nobel laureate who devoted his life to unravelling the complexities of the human brain The Science Show 16th January 2021

GuestsDavid MarkNational Sport Reporter ABC

Jonathan WebbScience Editor ABC

PresenterRobyn Williams

ProducerDavid Fisher

Read the original:
ANU plans to end neuroscience research - The Science Show - ABC News

What causes trypophobia? The neuroscience behind the fear of closely-packed holes – BBC Focus Magazine

Are you sitting uncomfortably? Does the picture below make you feel uneasy, unexpectedly nauseous or even terrified? Then weve got news for you: you probably suffer from a degree of trypophobia, an aversion to clusters of small holes.

Dont worry, youre not alone. While its estimated nearly 20 per cent of people are severely repulsed by pictures like the lotus pod above, some scientists think the majority of people react in some form to these images.

I think we all have trypophobia, just to different degrees, says Dr Geoff Cole, one of the first scientists to study the disorder. Just like many other psychological phenomena autism, for instance everyone is on the scale.

A lotus seed pod Getty

However, despite one in five people having severe trypophobia (double the estimated amount of people prone to claustrophobia), the disorder is remarkably under-researched.

This is essentially because nobody was aware of it until the internet developed and these images were shared in forums, says Cole, who published the first scientific paper on the topic (with co-author Prof Arnold Wilkins) in 2013. Because weve just noticed this phenomenon, there is still quite a lot we dont know.

But what has been discovered so far? And can scientists explain why people hate these hole-riddled images? We dig into the issue below alongside more pictures that some may find very uncomfortable. Consider yourself warned.

Its easy to be sceptical about trypophobia, a phobia that came to prominence through chatrooms in the early noughties. Even its name (Greek for boring holes plus fear) emerged from an internet forum away from the gaze of medical professionals.

However, despite these questionable beginnings, Cole has shown that images with high contrasts between dark and light, repeated many times in a field of view (about three times per centimetre at arms length), can have a real impact on a persons body.

A collection of lotus seed pods Getty

His research has shown trypophobic peoples heart rates can significantly increase when looking at images of hole clusters be it honeycomb, aerated chocolate or even crumpets. Sufferers can also experience nausea, sweating, itchiness and debilitating panic attacks.

Cole also defines trypophobia as a mental disorder. Think of it as the visual equivalent of somebody scratching their nails down a chalkboard the brain doesnt like these neural spikes these images create, he says.

At the moment, theres no one agreed explanation to what causes trypophobia. But scientists have developed several theories four, to be precise:

A poison dart frog Getty

A theory originally put forward by Cole, it proposes humans have evolved to be fearful of such patterns as they are usuallyseen on poisonous animals or food.

If you look at animals which are dangerous in this respect, like the poison dart frog, they tend to be covered in high contrast colours. These visual signatures are barely found anywhere else in the natural world, explains Cole.

Basically, the idea here is that when you look at a trypophobic image your brain is saying be careful here, this could harm you.

Read more about phobias:

Like the above, this explanation suggests trypophobia is an evolutionary adaptation: as many skin diseases have trypophobic traits, humans have evolved to pay these patterns attention.

It follows the thinking that humans have developed a sensitivity towards skin pathology, says Cole. In this way, its possible that a trypophobic reaction keeps us alert to any illness, either on ourselves or others.

The current favourite of researchers like Cole, this theory proposes, that we cant quite be sure what causes it that trypophobia serves no functional purpose and has no solid evolutionary adaptation.

The neuroscience behind this theory is quite interesting. Recently we used a technique called infrared spectroscopy to examine people with trypophobia its a method that allows you to see where the blood and activity are in somebodys brain, says Cole.

And on seeing trypophobic images, the blood was found towards the back of participants brains it was in the visual areas of the brain, rather than the frontal decision-making areas.

As Cole says, this may indicate a trypophobic response may not be prompting us to make a decision about how dangerous an object is. It indicates there might not be an evolutionary reason why we dont like these images it may simply just be that the brain doesnt like it. And we might never know more than this.

What if trypophobia didnt actually exist at all before it became big in internet forums? What if humans have been trained to think these images are something to fear due to online hype? Thats the explanation some have put forward.

Its the whole nature versus nurture argument: are people really born with a revulsion to things like rats? Or are we socially conditioned to be afraid of them? says Cole.

As some people argue, isnt it strange that more people develop phobias of spiders, but not cars, which are more likely to kill you? Theres a massive debate about phobia acquisition here that may never be solved.

As many review papers have noted, its difficult to examine genetic factors from social no phobia studies have yet been carried out on identical twins raised in different households.

True, in one study six-month-old infants were shown to have slightly higher levels of fight or flight chemical norepinephrine when presented with images of snakes and spiders, compared to flowers and goldfish. But this alone does not prove common human phobias and fears are in-built.

And with trypophobia its getting harder to separate nature from nurture, particularly with results. As these images become more popular online, how likely is it you can find an adult that has never seen a trypophobic image before and test them?

In short, when it comes to trypophobia, its getting more and more unlikely well know the hole truth.

A researcher at the University of Essex, Cole studies visual attention, cognitive neuropsychology and evolution.

Read more about the science of fear:

Read more here:
What causes trypophobia? The neuroscience behind the fear of closely-packed holes - BBC Focus Magazine

Neuroscience Cafe Presents COVID-19 Update: – Where Are We With Testing, Treatment, and Vaccination? – thehomewoodstar.com

Join us each month as UAB neuroscientists and clinicians present and discuss how neuroscience research is improving life in your community.

Studies show that COVID-19 vaccines are effective at keeping you from getting COVID-19. Experts also think that getting a COVID-19 vaccine may help keep you from getting seriously ill even if you do get COVID-19. Because COVID-19 is a new disease with new vaccines, information is rapidly emerging about how vaccines can help us stop the pandemic. Drs. Jeanne Marazzo and David Kimberlin wil discuss what we knowand what we dont knowabout the Covid vaccines.

This event is free.

To join the Zoom meeting, email: cnc@uab.edu to register for your zoom link.

View post:
Neuroscience Cafe Presents COVID-19 Update: - Where Are We With Testing, Treatment, and Vaccination? - thehomewoodstar.com

MPM Capital Strengthens Team with the Addition of Neuroscience R&D Leader David S. Bredt, MD, PhD as Executive Partner – Yahoo Finance

MPM Capital (MPM), a leading biotechnology investment firm investing in early-stage therapeutics companies, today announced that David S. Bredt, MD, PhD, has joined its team of Executive Partners.

"Were delighted to have David join MPM. His drug discovery expertise will be broadly applied to the MPM portfolio with a particular emphasis on building new companies addressing disorders of the central nervous system," said Ed Hurwitz, managing director at MPM Capital. "We see tremendous advances in the understanding of neurological dysfunction particularly in the areas of protein trafficking, neuroinflammation, neuroregeneration and ion-channel modulation. We fully expect Davids technical and managerial expertise will be of tremendous value as we delve into these exciting new opportunities."

David will take a leading role in helping MPM explore a range of opportunities, including those presented by new developments in the understanding of neurological dysfunction. This will include identifying and assessing new technologies and helping advance MPMs company formation efforts in the field of neurology.

"I am thrilled to join MPM Capital and to bring leadership in both drug discovery and the field of neurology to this accomplished team," said Dr. Bredt. "These are unprecedented times both of therapeutic need and of scientific progress. MPM has an impressive record of creating transformational biotechnology companies; I look forward to innovating with the team to deliver breakthrough new health care solutions to patients."

David S. Bredt, M.D., Ph.D.

Before joining MPM, David was Site Head for Johnson & Johnsons R&D Campus in La Jolla, which focuses on Neuroscience, Immunology and Biotechnology and is the original JLABS incubator for emerging healthcare companies. He was Global Head of Neuroscience Discovery at Johnson & Johnson where he had line management responsibility for neuroscience biology, biomarkers, and external innovation activities. His discovery group delivered numerous small and large molecule clinical candidates for Alzheimers disease, major depression, schizophrenia and epilepsy.

Story continues

David joined Eli Lilly and Company as Vice President of Integrative Biology in August 2004 and became Vice President of Neuroscience Discovery and Early Development a few years later. As head of neuroscience research at Eli Lilly, Davids group was responsible for Discovery through Phase 2 programs in Neurology, Psychiatry, Migraine, and Pain indications. His group prosecuted numerous small and large molecules that entered preclinical and clinical development including galcanezumab / Emgality, which is now approved for preventative treatment of migraine.

David graduated summa cum laude in Chemistry at Princeton University. He received his M.D. and Ph.D. at Johns Hopkins University School of Medicine, where he trained with Dr. Solomon H. Snyder. After graduation, David was Professor of Physiology at the University of California, San Francisco for ten years. His research on nitric oxide, glutamate receptor signaling, and synaptic plasticity has yielded ~225 papers, which have been cited ~75,000 times in the scientific literature. He served on the Medical Advisory Committee for the Muscular Dystrophy Association, he was an Established Investigator for the American Heart Association, and he was a National Young Investigator for the National Science Foundation.

About MPM Capital

MPM Capital is a biotechnology investment firm with over two decades of experience founding and investing in companies that seek to translate scientific innovations into cures for major diseases. With its experienced and dedicated team of investment professionals, entrepreneurs, and advisors, MPM strives to power novel medical breakthroughs that transform patients' lives. For more information visit http://www.mpmcapital.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20210407005554/en/

Contacts

Matt Burkemattdavidburke@gmail.com +1 603.315.0618

Read the original here:
MPM Capital Strengthens Team with the Addition of Neuroscience R&D Leader David S. Bredt, MD, PhD as Executive Partner - Yahoo Finance

Leaking calcium in neurons an early sign of Alzheimer’s pathology – Yale News

Alzheimers disease is known for its slow attack on neurons crucial to memory and cognition. But why are these particular neurons in aging brains so susceptible to the diseases ravages, while others remain resilient?

In a new study published April 8 in the journal Alzheimers & Dementia, The Journal of the Alzheimers Association, researchers at the Yale School of Medicine found that susceptible neurons in the prefrontal cortex develop a leak in calcium storage with advancing age. This disruption of calcium storage in turns leads to accumulation of phosphorylated, or modified, tau proteins which cause the neurofibrillary tangles in the brain that are a hallmark of Alzheimers.

These changes occur slowly, building over many years, and can be seen within neurons in the brains of very old monkeys, the researchers report.

Altered calcium signaling with advancing age is linked to early-stage tau pathology in the neurons that subserve higher cognition, said corresponding author Amy Arnsten, the Albert E. Kent Professor of Neuroscience and professor of psychology and member of the Kavli Institute of Neuroscience at Yale University.

These vulnerable neurons face another problem. As they age, they tend to lose a key regulator of calcium signaling, a protein called calbindin, which protects neurons from calcium overload, and is abundant in the neurons of younger individuals.

With age, these neurons face a double whammy, with an excessive calcium leak that initiates toxic actions, as well as diminished levels of the protectant, calbindin, said Arnsten.

Neurons in the prefrontal cortex require relatively high levels of calcium to perform their cognitive operations, but the calcium must be tightly regulated. However, as regulation is lost with increasing age, neurons become susceptible to tau pathology and degeneration. Essentially, neurons eat themselves from within.

Understanding these early pathological changes may provide strategies to slow or prevent disease progression, Arnsten said.

The study is a collaboration between the labs of Arnsten and Angus Nairn at Yale; Dibyadeep Datta and Shannon N. Leslie are co-first authors of the research.

See the original post here:
Leaking calcium in neurons an early sign of Alzheimer's pathology - Yale News

Neuroscience Market in Healthcare Market Is Thriving Worldwide with the outstanding players KSU | The Sentinel Newspaper – KSU | The Sentinel…

The global Neuroscience Market is estimated to be valued at US$ XX billion in 2020 and is projected to reach US$ XX billion by 2027, recording a CAGR of XX %.

COVID-19 Impact on Global Neuroscience Market

We at Coherent Market Insights understand the economic impact spread to financial markets. Using our holistic market research methodology, we are focused on aiding your business sustain and grow during COVID-19 pandemics. With deep expertise across various industries-no matter how large or small and a team of highly experienced and dedicated analysts, Coherent Market Insights will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/2487

National governments and international are focused on adopting collaborative efforts to encourage financial institutions to meet the financial needs of customers and members affected by the coronavirus. However, there are some sectors that have remained unscathed from the impact of the pandemic and there are some that are hit the hardest.

Global Neuroscience Market: Segments

North America United States Canada MexicoAsia Pacific China Japan South Korea India Australia Indonesia Thailand Malaysia Philippines VietnamEurope Germany France UK Italy RussiaCentral & South America Brazil Middle East & Africa Turkey GCC Countries Egypt South Africa

Global Neuroscience Market: Regional Outlook

The Neuroscience held dominant position in the market and accounted for XX% share in the global Neuroscience Market in 2020. The segment is expected to reach US$ XX million in 2027.

Apply Promo Code CMIFIRST1000 And Get Instant Discount Of USD 1000

Buy This Research Study Report For Quick [emailprotected] https://www.coherentmarketinsights.com/insight/buy-now/2487

Global Neuroscience Market: Key Participants

Major players operating in the global Neuroscience Market include: Alpha Omega, Inc., GE Healthcare, Axion Biosystems, Inc., Siemens Healthineers, Blackrock Microsystems LLC, Femtonics Ltd., Intan Technologies, LaVision Biotec GmbH, Mediso Medical Imaging Systems, Neuralynx Inc., NeuroNexus Technologies, Inc., Newport Corporation, Plexon Inc., Noldus Information Technology, Scientifica Ltd., Sutter Instrument Corporation, Thomas Recording GmbH, and Trifoil Imaging Inc.

The report covers exhaustive analysis on:

Market Segments Market Dynamics Market Size Supply & Demand Current Trends/Issues/Challenges Competition & Companies involved Technology Value Chain

Regional analysis includes:

North America (United States, Canada, and Mexico) Asia Pacific (China, Japan, South Korea, India, Australia, Indonesia, Thailand, Malaysia, Philippines, and Vietnam) Europe (Germany, France, UK, Italy, and Russia) Central & South America (Brazil) Middle East & Africa (Turkey, GCC Countries, Egypt, and South Africa)

Report Highlights:

Detailed Overview Market Dynamics Detailed Market Segmentation Historical, Current, and Projected Market Size in terms of volume and value Market Trends and Developments Competitive Landscape Strategies of Key Players Potential and Niche Segments

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. ShahCoherent Market Insights1001 4th Ave, #3200Seattle, WA 98154Phone: US +12067016702 / UK +4402081334027Email: [emailprotected]

See the original post:
Neuroscience Market in Healthcare Market Is Thriving Worldwide with the outstanding players KSU | The Sentinel Newspaper - KSU | The Sentinel...

Neuroscience Market Development And Trends, CAPEX Cycle, Innovations, And The Dynamic Structure Forecast 2021-2027 – The Courier

The latest SMR Reports study titledNeuroscience Markethighlights important aspects of the Neuroscience market. The report is intended to help readers accurately estimate the growth rate of the world market during the forecast period (2020-2026). Our market research team has meticulously assessed the Neuroscience market dynamics, both quantitatively and qualitatively, taking into account a variety of factors including market penetration, product portfolios, user industries, results, pricing structure, and key drivers, restraints, opportunities, and challenges. affect market growth.

Neuroscience Market garnered revenue of USD 1.8 billion in the year 2020 globally and has been foreseen to yield USD 5.4 billion by the year 2026at a compound annual growth (CAGR) of 6.9% over the forecast period.

The latest market research largely segments the industry based on product types, application areas, end-use industries, key regions, and competitive environment. One of the central components of the report is a detailed explanation of the gross profit, the share of sales, the sales volume, the manufacturing costs, the individual growth rate, and the financial position of the main market participants. The scope of development of newcomers and established companies in the Neuroscience market was also highlighted in the report.

Download Exclusive Sample PDF along with few company profiles @https://www.syndicatemarketresearch.com/sample/neuroscience-market

Competitive Field:

The Neuroscience market is highly consolidated due to the presence of many companies operating in this sector. The report describes the current market position of these companies, their past performance, graphs of supply and demand, production and consumption patterns, distribution network, sales channels, and growth opportunities in the market. The main market candidates listed in the report are:

Market Segments by Major Manufacturers:Doric Lenses Inc, GE Healthcare, Siemens Healthineers, Laserglow Technologies, Mightex Systems, Prizmatix, Kendall Research Systems LLC, Noldus Information Technology, Med Associates Inc, Phoenix Technology Group, NeuroNexus

Impact Of COVID-19

The most recent report includes extensive coverage of the significant impact of the COVID-19 pandemic on the Neuroscience division. The coronavirus epidemic is having an enormous impact on the global economic landscape and thus on this special line of business. Therefore, the report offers the reader a clear concept of the current scenario of this line of business and estimates the aftermath of COVID-19.

Request a Discount on the report @https://www.syndicatemarketresearch.com/inquiry/neuroscience-market

Market Segments and Sub-segments Covered in the Report are as follow:

Neuroscience Market, By End-User

Whole Brain Imaging, Neuro-microscopy, Electrophysiology, Neuro-functional analysis, Neuro-proteomic analysis, Neuro-cellular manipulation, Neuro-biochemical assays, Stereotaxic surgeries, Animal behavior

Neuroscience Market,By Application (2020-2026)

Instrumentation, Data Analysis and Services, Consumables

In this section of the report, market analysts have provided valuable insight into the geographic segmentation of the Neuroscience market. They further estimated the current and future market valuations based on the demand and supply dynamics and the pricing structure of the key regional segments. In addition, the growth prospects for each regional segment were discussed in detail in the report.

The Neuroscience Market is divided into the following regions:

North America

Latin America

Europe

Asia Pacific

The Middle East and Africa

Request customization of the report @https://www.syndicatemarketresearch.com/market-analysis/neuroscience-market.html

In continuation with this information, the sale worth is for varied sorts, applications, and regions also are enclosed. The marketplace for major regions is given. In addition, sort wise and application wise consumption figures also are given.

Thanks for reading this article; you can also get individual chapter wise section or region wise report versions like North America, Europe, or Asia Pacific.

How Syndicate Market Reports is different than other Market Research Providers:

Go here to read the rest:
Neuroscience Market Development And Trends, CAPEX Cycle, Innovations, And The Dynamic Structure Forecast 2021-2027 - The Courier

School of Education & Human Sciences to host 3rd session of virtual series for 2020-21 | The University of Kansas – KU Today

LAWRENCE The School of Education & Human Sciences at the University of Kansas will host the third and final virtual session of the 2020-21 Strategies Event Series on April 17 via Zoom.

The third session, Understanding Educational Neuroscience Research, will feature Michael Orosco, associate professor in the Department of Educational Psychology. The session will address advances in educational neuroscience research that has given educators insight into the workings of the mind and brain. Participants will be able to apply information about how learning and teaching affects their students brains and their capacity to grow.

We are pleased to offer another free professional development session, this time focusing on research related to neuroscience and its significance for teaching and learning, said Rick Ginsberg, dean of the School of Education & Human Sciences. Dr. Oroscos expertise in this area provides vital information for todays educators.

Oroscos virtual session will take place at 9 a.m. The session is free and open to the public, though individuals must RSVP online to receive the Zoom access information for participation. Learn more and RSVP for the session online.

About the KU School of Education & Human Sciences

Located in Lawrence, the KU School of Education & Human Sciences is a nationally ranked school, preparingeducators and human science professionals as leaders since 1909. With more than 40 academic programs offered among five departments, at two different campuses and fully online, the school serves Kansas, the nation and the world by preparing individuals to become leaders and practitioners in education and related human science fields. Stay up to date by following the School on Facebook, Twitter, and Instagram.

Link:
School of Education & Human Sciences to host 3rd session of virtual series for 2020-21 | The University of Kansas - KU Today